Page last updated: 2024-12-07

cor 32-24

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

COR 32-24: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID93499
CHEMBL ID4741106
MeSH IDM0159656

Synonyms (21)

Synonym
5-[(4-phenylpiperazin-1-yl)methyl]-4,5-dihydro-1,3-oxazol-2-amine
cor-32-24
cor-3224
2-amino-5-(4-phenyl-1-piperazinylmethyl)-2-oxazoline
cor 32-24
4,5-dihydro-5-(4-phenyl-1-piperazinylmethyl)-2-oxazolamine
4,5-dihydro-5-(methyl(4-phenyl-1-piperazinyl))-2-oxazolamine
cor 3224
2-oxazolamine, 4,5-dihydro-5-((4-phenyl-1-piperazinyl)methyl)-
5-(1-phenyl-4-piperazino)methyl-2-amino-oxazoline
91595-86-7
2-oxazolamine, 4,5-dihydro-5-[(4-phenylpiperazin-1-yl)methyl]-
XSZLHACSCSAKOF-UHFFFAOYSA-N ,
5-[(4-phenyl-1-piperazinyl)methyl]-4,5-dihydro-1,3-oxazol-2-amine #
cor3224
5-[(4-phenylpiperazin-1-yl)methyl]-1,3-oxazolidin-2-imine
DTXSID00919643
pipoxazole
CHEMBL4741106
PD159865
AKOS040749213

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" This method allowed the determination of pharmacokinetic parameters in six beagle dogs after intravenous and oral administration of 14C-labeled 1 ([14C]1) in a crossover study."( High-performance liquid chromatography of a new 2-amino-2-oxazoline: application to pharmacokinetic studies in dogs.
Damaj, MI; Jacquot, C; Lambrey, B; Trouvin, JH, 1990
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's6 (85.71)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.01 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index5.09 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]